These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38891066)

  • 1. End Organ Affection in Sickle Cell Disease.
    Bathla T; Lotfollahzadeh S; Quisel M; Mehta M; Malikova M; Chitalia VC
    Cells; 2024 May; 13(11):. PubMed ID: 38891066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 gene editing for curing sickle cell disease.
    Park SH; Bao G
    Transfus Apher Sci; 2021 Feb; 60(1):103060. PubMed ID: 33455878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the diagnosis and treatment of sickle cell disease.
    Brandow AM; Liem RI
    J Hematol Oncol; 2022 Mar; 15(1):20. PubMed ID: 35241123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease; a general overview.
    Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
    Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction.
    Nader E; Conran N; Romana M; Connes P
    Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients.
    Ellithy HN; Yousri S; Shahin GH
    Hematology; 2015 Dec; 20(10):598-606. PubMed ID: 25880856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state of gene therapy in sickle cell disease.
    Tang MS; Shan H
    Vox Sang; 2024 Jun; 119(6):521-528. PubMed ID: 38487952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.
    Li H; Kazmi JS; Lee S; Zhang D; Gao X; Maryanovich M; Torres L; Verma D; Kelly L; Ginzburg YZ; Frenette PS; Manwani D
    Blood; 2023 Jan; 141(2):194-199. PubMed ID: 36315910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crises in Sickle Cell Disease.
    Novelli EM; Gladwin MT
    Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease: an update.
    Conway O'Brien E; Ali S; Chevassut T
    Clin Med (Lond); 2022 May; 22(3):218-220. PubMed ID: 35584832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac complications of sickle cell disease in children].
    Astadicko I; Dresse MF; Seghaye MC
    Rev Med Liege; 2018 Nov; 73(11):550-556. PubMed ID: 30431243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hamali HA
    Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving treatment paradigms in sickle cell disease.
    Jagadeeswaran R; Rivers A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle Cell Disease: A Brief Update.
    Azar S; Wong TE
    Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice.
    Yalamanoglu A; Dubach IL; Schulthess N; Ingoglia G; Swindle DC; Humar R; Schaer DJ; Buehler PW; Irwin DC; Vallelian F
    Front Immunol; 2021; 12():627944. PubMed ID: 33763072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.